When compared to control subjects, AGS participants showed an increased expression of genes associated with the NFkappaB pathway, and the transcriptional regulation of immune genes, antigen processing and presentation, type 2/Th2 immune responses, itch, and allergic dermatitis (Table S3). The gene discussed is NFKB1; the disease is atopic eczema.